Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients - 27/04/12
, O. Poutanen a, b, A. Illi a, E. Setälä-Soikkeli c, M. Viikki a, e, T. Nuolivirta d, E. Leinonen a, b
Corresponding author.Tel.: +358 44 4155547(mobile); fax: +358 3 35516164.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objective |
The Temperament and Character Inventory (TCI) is commonly used in adult populations. Our aim was to explore: (1) if there are specific differences in temperament dimensions related to depression in comparison with general population, (2) if the treatment response during the acute phase of major depressive disorder (MDD) is predictable by TCI temperament dimensions.
Method |
Temperament profiles in 98 MDD patients were compared with a Finnish community sample. The patients were treated with serotonin selective reuptake inhibitors (SSRIs) for 6weeks and their temperament profiles were assessed at baseline and endpoint. The harm avoidance (HA) and depression scores at baseline and endpoint were modelled with path analysis. For path modelling, we tested the relationships between different temperament dimensions and depression symptoms and other clinical variables with Mancova model.
Results |
The HA scores were significantly higher in patients both at baseline and endpoint compared to the Northern Finland 1966 Birth Cohort (NFBC). The patients, and especially males, had slightly higher reward dependency (RD) scores. HA at endpoint explained moderately the Montgomery Åsberg Depression Rating Scale (MADRS) endpoint score. HA endpoint score was strongly explained by HA baseline score.
Conclusions |
HA is associated with risk of and treatment response to depression.
Le texte complet de cet article est disponible en PDF.Keywords : Temperament, Inventories, Major depression, Antidepressive agents, Second generation, Therapeutic use
Plan
 | The work was done in Tampere Mental Health Care Centre and Kanta-Häme Central Hospital, Department of Psychiatry. |
Vol 27 - N° 4
P. 245-249 - mai 2012 Retour au numéro
Article précédent
- The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study
- I.M. Lako, K. Taxis, R. Bruggeman, H. Knegtering, H. Burger, D. Wiersma, C.J. Slooff
- Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mg
- T. Sanglier, D. Milea, D. Saragoussi, M. Toumi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?